[Use of anticoagulant therapy in cancer].
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D005341:Fibrinolysin / Q000627:therapeutic use; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin; D006493:Heparin; D010447:Peptide Hydrolases; D005341:Fibrinolysin
Primenenie antikoagluliantnoĭ terapii u onkologicheskikh bol'nykh